Enliven: Challenges in Cancer Detection and Therapy is an Open access, peer reviewed international journal and it aims to publish different types of articles on emerging developments and supports current and upcoming research in the field of cancer. This journal also allows articles on tumor studies, oncology and radiation.
This journal will support the budding scientists, scholars, academicians, researchers, and students by providing Open access platform for publishing their work.
This journal will follow the peer review policies and will bode Open access in having quality research output.
Enliven: Challenges in Cancer Detection and Therapy invites articles from authors and we assure authors that articles received will be processed with the best policies and will disseminate the articles to the right field.
Enliven: Challenges in Cancer Detection and Therapy journal is interested to publish high quality original research and reviews in all areas of cancer and related fields.
This journal invites articles from all areas like molecular, subcellular, cellular, organ, clinical and translational studies of cancer.
This journal supports to exchange ideas, concepts and findings, discoveries, and current developments in cancer, oncology research, and related fields. This journal provides the Open Access forum to quick and effective dissemination of new research in cancer for better world.
Official Media Partners:
Scientific Federation invites all the participants from all over the world to attend 2nd International Conference on Women Health and Breast Cancer during May 24-25, 2018 at Valencia, Spain which includes Keynote presentations, Oral talks, Poster presentations and Exhibitions.
Women Health-2018 will also provide the excellent opportunity to meet experts, exchange information, and strengthen the collaboration among Directors, Researchers, Associate Professors, and Scholars from both academia and industry.
2nd International Conference on Women Health and Breast Cancer is anticipating participants from 40 and more countries across the globe and the two day conference will provoke Plenary sessions, Keynote speeches, Poster, and Oral presentations. This program provides two days of robust discussions on recent advancements and new strategies for development of new materials for global requirements.
On 10 & 11 May 2018, Singapore will host the BioTech Pharma Summit: Tumor Models 2018 conference. This year’s event is bringing together industry and academic leaders from the preclinical and translational oncology community all over the World. Succeed in producing more predictive and clinically relevant preclinical research when developing your Immuno-Oncology therapies
Go through: https://biotechpharmasummit.com/index.php/event/tumor-models-2018/ for further details
The 7th World Congress on Breast Cancer, which is going to be held during May 10-11, 2018 at Frankurt, Germany . Breast Cancer 2018 will be the world best platform for all the individuals like Gynecologists, Pediatricians, Surgeons, Physicians and Nurses who are dealing with Women's Health and Midwifery. The main theme of the conference is “Pioneering Spirit of Enriching the Lives and Wellness of Women”.
Why to Attend???
• Breast Cancer 2018 provides a global platform for exchanging ideas and makes us updated about the latest innovations in Breast Cancer and Women’s Health
• Opportunity to attend the presentations delivered by Eminent Scientists from all over the world
• Accepted abstracts will be published in Journal of Breast Cancer and Cancer and provided with DOI
• Global networking: In transferring and exchanging Ideas
• Best poster presentations and young Scientist Awards
Web URL: http://breastcancer.conferenceseries.com/
Conference Series invites all the experts around the world to attend the International Conferences on Cancer Diagnosis and Treatment going to be held in Oslo, Norway from August 2-3 2018. Theme of the conference Torch your light to develop a cancer- free world.
Cancer Diagnosis and Treatment conference 2018 will acts as a forum for Directors, Professors, Researchers, Oncologists, Cancer Specialist, Students, Foundation Leaders, Industrial Professional, Statisticians, Clinicians, Academicians, Medical Oncologists and others from all over the world to share their values knowledge and experience about the Cancer research, to stimulate Young Researcher on new ideas for treatment and analyses of the current market and for the future direction in cancer vaccine, instrument with less side effect of therapy.
Cancer Diagnosis and Treatment Conferences 2018 involved with many interactive sessions on cancer detection, therapies, control, prevention, advancements in the oncology, posters, symposia, workshops, industry presentation, panel discussion, exhibition, Young Researcher Forums(YRF).
Euroscicon welcomes all the participants from all over the world to attend “2nd Edition of International Conferences on Clinical Oncology and Molecular Diagnostics” during June 11-13, 2018 at Dublin, Ireland. Clinical oncology 2018 which is one of the best oncology conferences aims to gather prominent educational scientists, researchers and instructors to share their experiences and ideas. As the theme of the conference "Enlightening the Future Panorama of Clinical Oncology", the major discussion points will be based on the novel advancements in clinical oncology. This cancer conference includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. The significant sessions in this conference are Cancer Metastasis, Cancer Biopsy, Cancer Epigenetics, Cancer Screening, Cancer Epidemiology, Cancer Biomarkers, Oncogenomics and Radiation Oncology. The purpose of Clinical Oncology Conference is to promote interest, stimulate research, develop drugs and promulgate information on all aspects of cancer science.
Website URL: http://oncology.euroscicon.com/
Clinical Oncology Conferences
High stone House, 165 High Street
Barnet, Hertfordshire EN5 5SU, UK
Tel: (+44) 020 3807 3712 (Europe/UK)
Email: email@example.com, firstname.lastname@example.org
Conference Name: International conference on Biomarkers and Cancer Targets 2018
Date: 16-17 july 2018
Venue: Dubai UAE
Conference short name:- Cancer Targets 2018
Cancer target 2018 is organized around the theme: “A Lifesaving mission to end cancer forever”. Cancer Targets 2018 is a well organised scientific event consisting workshops,symposiums, exhibitions of oncological instruments, new diagnostic therapies and special sessions for young researchers and students with modern and advance research from top universities, research centres, hospitals. The unique international on biomarker and cancer target conference 2018 directs towards addressing main issues as well asfuture strategies s of cancer. This is going to be the largest and most promising international conference where the researcher as well as decision makers will come to discuss and debate on various aspects of the challenges, risks and investment opportunities throughout the complete information of cancers.
EuroSciCon invites the participants from all over the world to attend the 3rd Edition of International Conference on Colorectal Cancer 2018, this Colorectal Cancer Conference will assemble recent researches & findings, oral talks, poster presentation and exhibition in colorectal cancer, colorectal cancer therapies and other issues in colorectal cancer research and its science from October 11-12th, 2018 in imperial Capital Zurich, Switzerland. The motive of this cancer conferences is "A scientific approach to enlighten about diagnosis and therapeutics in colorectal cancer" which will provide an international platform for discussion of present and future challenges in various kind of its genetical and immunological diseases, disorder, symptoms & analysis regard to colorectal cancer along with education and expertise meeting on oncology conferences.
Allied Academies cordially welcomes all theparticipants and contributors from worldwide to attend the Conference .It is to spread knowledge, awareness,and education about the recent advances in the treatment of cancer and development of a new treatment to reduce the death rate because of cancer and to develop painless treatment ofcancer. With people from around the world focused on getting some answers concerning CancerScience and Therapy,this is your single most obvious opportunity to accomplish the greatest accumulation of individuals from the mending focuses, Universities, bunch,etc.
12th World Cancer Congress invites all experts in cancer, from all over the world to gather at Moscow, Russia on July 23-25, 2018 to step up yourselves as a most excellent person at your career. This cancer conference is your international platform. This cancer conference goal is to gather cancer researchers, therapist, oncologist, doctors, biologist, students, cancer motivational speakers, cancer challengers, pharmaceutical companies, biotechnology companies and business Entrepreneurs across the globe to provide international research
knowledge about cancer.
The theme of the cancer conference is ‘Gather for No Cancer Destiny’ which would enhance all cancer researchers to assemble together present their research works towards terminating cancer.
Cancer Conference 2018 with excellent scientific program for all the three days which includes global cancer experts 20+ keynote talk, 50+ plenary talk, 50+ posters, 30+ video presentations, 2+ workshops and 2+exhibitions.
Cancer conference 2018 will cover every aspects of cancer research which in turn will help cancer community to work further towards terminating cancer.
“23rd International Conference on Cancer Research and Pharmacology” is a hallmark in the era of cancer conferences with its eminent speakers and notable organizing committee members. The realization of cancer therapeutics with less of an effect on normal tissues and life of cancer patients is our goal. This goal is still far from being realized, and novel approaches are progressing. This conference will focus on current advances in cancer research and pharmacology aiming to the goal.
The realization of cancer therapeutics with less of an effect on normal tissues and life of cancer patients is our goal. This goal is still far from being realized, and novel approaches are progressing. This conference will focus on current advances in cancer research and pharmacology aiming to the goal.
Breast and Cervical cancer Conference welcomes you to grace with your presence. 3rd World Conference on Breast and Cervical Cancer to be held at Abu Dhabi, UAE during September 27-28, 2018. This 3rd Breast and Cervical Cancer conference will bring together cancer researchers, oncologists, professors and scientists to discuss strategies for Breast and Cervical Cancer globally. BreCeCan 2018 is designed to provide divergent and prevailing education that will gather Oncology professionals’ familiar of the issues affecting the advancements, applications and innovations in the field of Cancer science. Undoubtedly the participant at this BreCeCan 2018 conference will be able to exchange with the best experts in the specialty and will return home with extensive knowledge.
Conference URL: https://liver.cancersummit.org/
Conference Brochure: https://liver.cancersummit.org/conference-brochure.php
Conference Series warmly invite all the experts working in the arena of Biomarkers and related field to its up coming 14th Global Biomarker Summit (Biomarker Summit 2018), scheduled from October 18-19, 2018, Amsterdam, Netherlands.
This Biomarker Conference is based on the theme “Challenges in Biomarker Developments from Discovery to Translation & Commercialization”.
150+ delegates from Global Pharma & Bio Pharma Companies. CROs, hospitals, Biotech firms, renowned institutes and Universities are expected to participate at this Biomarker Summit. 30+ case studies, presentations, panel discussions, plenary sessions, Poster Presentations, e-Poster Presentations, Young Researcher Forums will be scheduled to discuss the current trends, issues and novel discoveries in Biomarker Discovery, Biomarker research, clinical applications of Biomarkers, companion diagnostics, personalized medicine, Clinical & Translational Research in Biomarkers etc. To encourage the Young Researchers across the globe, Global Biomarker Congress comes up with the Young Researcher Forum (YRF), Best poster & Oral Presentation Awards and Young Researcher awards.
Breast Cancer Conference is delighted to welcome the participants from all over the world to attend the prestigious International Conference on Breast Cancer scheduled during October 22-23, 2018 in Vancouver, Canada.
Breast Cancer Conference provides the global coliseum to international scholars and researchers to voice their research findings to the world. With representatives from all the major cancer biology countries in attendance the atmosphere is exciting with open and friendly interaction between attendees. This is a conference, providing an opportunity for the Cancer biology & Breast Cancer biology to learn about current and upcoming issues, explore new developments in breast cancer Biology, and interact with others with similar interests.
Is Intraperitoneal Chemotherapy a New Strategy for Diffuse Abdominopelvic Tumor in Pediatric Patients?Authors: Babak Abdolkarimi, Dr. Mahdi Shahriari, and Dr. Soheila Zareifar Abstract View Pdf Full Text
In Menopausal hormone therapy the Evidence on the use of progesterone.
- In clinical case studies the use of natural P4 in HT results, for the most part, in favorable outcomes without deleteriou effects of postmenopausal women.
In Breast cancer training emotional control to reduce the cognitive Vulnerability.
- Adaptive cognitive training cut down anxiety and rumination with accouterments evident at low and high term follow up assessments.
In breast cancer Raloxifene and Tamoxifen are used to risk level in a Medicare eligible Cohort.
- Over 5 years in breast cancer was assessed the modified gail model and self reported risk factors.
In breast cancer the HER2-positive is current and new therapeutic strategies.
- Surely, Despite these therapeutic aaproach most patients progress on therapy expected tp primary or acquired resistance or because of an incorrect HER2 positivity assessment.
The Combination of both Rational design and Identification of immuno-oncology drug.
- In 9089 tumors gene expression data from TCGA were mined to extract the 178 IO targets originating from 19 cancer types.